MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Gnetol

CAS No. : 86361-55-9

MCE 站：Gnetol

产品活性：Gnetol 是从 Gnetum ula Brongn 的根中分离出来的酚类化合物。Gnetol 有效抑制 COX-1 (IC₅₀ 为 0.78 μM) 和 HDAC。Gnetol 是一种有效的酪氨酸酶抑制剂，对鼠酪氨酸酶的 IC₅₀ 为 4.5 μM，可抑制黑色素的生物合成。Gnetol 具有抗氧化，抗增殖，抗癌和保肝活性。Gnetol 还具有浓度依赖性的 α-淀粉酶，α-葡萄糖苷酶和脂肪形成活性。

研究领域：Immunology/Inflammation  |  Metabolic Enzyme/Protease  |  Cell Cycle/DNA Damage  |  Epigenetics

作用靶点：COX  |  Tyrosinase  |  HDAC

In Vitro: The antiproliferative activities of Gnetol are tested in HCT-116, Hep-G2, MDA-MB-231, and PC-3 cell lines by measuring cell viability after treatment with 4.1 μM, 40.9 μM, 204.7 μM, 409.4 μM, and 1023.6 μM. Gnetol shows concentration-dependent reductions in cell viability in cancer cell lines with greatest activity in colorectal cancer.
Gnetol at 200 ?g/mL significantly offers the highest protection of 54.3% against the toxicant. A lower dose of Gnetol (50 ?g/mL) also shields the cell line from the toxic effects of CCl4.
The ligand molecule TGF-β and PPARα protein show that Gnetol has the binding affinity of 7.0 and 8.4, respectively.

In Vivo: Male Sprague-Dawley rats were cannulated and dosed either intravenously with Gnetol (10?μg/kg) or orally (100?mg/kg). After oral and intravenous administration, Gnetol is detected in both serum and urine as the parent compound and as a glucuronidated metabolite. The bioavailability of Gnetol is determined to be 6%. Gnetol is rapidly glucuronidated and is excreted in urine and via nonrenal routes.
Pretreatment of Male NIH Swiss mice (20-35 g) with Gnetol (50mg/kg, SC) is able to increase the latency period to response in analgesia models.

相关产品：Trichostatin A  |  4-Phenylbutyric acid  |  Acetaminophen  |  Valproic acid  |  Entinostat  |  Sulforaphane  |  Romidepsin  |  Indomethacin  |  Celecoxib  |  Aspirin  |  RGFP966  |  Tasquinimod  |  Ibuprofen  |  Corin  |  Tacedinaline  |  Catechin  |  NS-398  |  Diclofenac  |  20(S)-Ginsenoside Rg3  |  Taxifolin  |  2-Ketoglutaric acid  |  Naproxen  |  (-)-Epicatechin  |  Dacinostat  |  Gallic acid  |  ITSA-1  |  SIS17

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。